FI850449A0 - Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav. - Google Patents

Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav.

Info

Publication number
FI850449A0
FI850449A0 FI850449A FI850449A FI850449A0 FI 850449 A0 FI850449 A0 FI 850449A0 FI 850449 A FI850449 A FI 850449A FI 850449 A FI850449 A FI 850449A FI 850449 A0 FI850449 A0 FI 850449A0
Authority
FI
Finland
Prior art keywords
methoxyphenoxy
methylpiperidine
fluorophenyl
trans
framstation
Prior art date
Application number
FI850449A
Other languages
English (en)
Other versions
FI850449L (fi
Inventor
Jorgen Buus Lassen
Jorgen Anders Christensen
Erling Niels Petersen
John Bondo Hansen
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan As filed Critical Ferrosan As
Publication of FI850449A0 publication Critical patent/FI850449A0/fi
Publication of FI850449L publication Critical patent/FI850449L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI850449A 1984-02-07 1985-02-04 Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav. FI850449L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/577,844 US4585777A (en) 1984-02-07 1984-02-07 (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT

Publications (2)

Publication Number Publication Date
FI850449A0 true FI850449A0 (fi) 1985-02-04
FI850449L FI850449L (fi) 1985-08-08

Family

ID=24310381

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850449A FI850449L (fi) 1984-02-07 1985-02-04 Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav.

Country Status (12)

Country Link
US (1) US4585777A (fi)
EP (1) EP0152273B1 (fi)
JP (1) JPS60181071A (fi)
AT (1) ATE46146T1 (fi)
CA (1) CA1246082A (fi)
DE (1) DE3572807D1 (fi)
DK (1) DK53285A (fi)
ES (1) ES8601131A1 (fi)
FI (1) FI850449L (fi)
GR (1) GR850309B (fi)
IE (1) IE850286L (fi)
NO (1) NO850444L (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
GB9700690D0 (en) 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
HUP0003958A3 (en) 1997-05-29 2001-06-28 Smithkline Beecham Plc Process for preparation of 4-aryl-piperidines and intermediates
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
AU2002301956B2 (en) * 1997-06-10 2006-02-09 Synthon B.V. 4-phenylpiperidine compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
WO2001085688A1 (en) 2000-05-12 2001-11-15 Synthon B.V. TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS
EP1301508A1 (en) * 2000-07-17 2003-04-16 Smithkline Beecham Plc Novel processes for the preparation of 4-phenylpiperidine derivatives
WO2002028834A1 (en) * 2000-10-06 2002-04-11 Smithkline Beecham P.L.C. Process for the preparation of aryl-piperidine carbinols and intermediates thereof
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
NL1017421C2 (nl) 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
EP1406624A4 (en) * 2001-06-13 2005-03-30 Teva Pharma METHOD FOR PRODUCING PAROXETIN, WHICH IS ESPECIALLY FREE OF ALKOXY POLLUTION
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
CN101855218A (zh) * 2007-09-13 2010-10-06 康塞特医药品有限公司 氘化的儿茶酚和苯并[d][1,3]间二氧杂环戊烯及其衍生物的合成

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds

Also Published As

Publication number Publication date
DK53285A (da) 1985-08-08
FI850449L (fi) 1985-08-08
ES540172A0 (es) 1985-11-16
NO850444L (no) 1985-08-08
DK53285D0 (da) 1985-02-06
GR850309B (fi) 1985-06-05
EP0152273A3 (en) 1986-12-30
EP0152273A2 (en) 1985-08-21
IE850286L (en) 1985-08-07
EP0152273B1 (en) 1989-09-06
US4585777A (en) 1986-04-29
JPS60181071A (ja) 1985-09-14
ATE46146T1 (de) 1989-09-15
ES8601131A1 (es) 1985-11-16
CA1246082A (en) 1988-12-06
DE3572807D1 (en) 1989-10-12
JPS6135176B2 (fi) 1986-08-12

Similar Documents

Publication Publication Date Title
FI850449L (fi) Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav.
NO174239C (no) Fremgangsmåte for fremstilling av et oralt, farmasöytisk preparat
NO873091L (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
FI892603A (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 4-(kinolin-2-yylimetoksi)fenyylietikkahappojohdannaisten valmistamiseksi
NO862861D0 (no) Fremgangsmaate for fremstilling av distamycinderivater.
YU45719B (sh) Postopek za pripravo mešano substituiranih enantiomerno čistih 1,2-diacil-sn-gli cero-3-fosfoholinov in 1,2-di-acil-sn-glicero-3-fosfoetanolaminov
PT87854A (pt) Process for the preparation of thio-urea derivatives
NO872463D0 (no) Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning.
DE3874229D1 (de) Verwendung von dioxopiperidin-derivaten zur herstellung eines topischen praeparates als analgetika.
DE3577443D1 (de) Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.
NO872574L (no) FremgangsmŸte for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
NO863616L (no) Fremgangsmaate for fremstilling av n-sulfamyl-3-(2-guanidinothiazolo-4-yl-methylthio)-propionamid.
FI890864A (fi) Anvaendning av 1,4-dihydropyridinderivat.
NO872393L (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO864525D0 (no) Fremgangsmaate ved fremstilling av aryleddiksyrederivater.
SE8500822L (sv) Diazepinoindoler, deras framstellning samt farmaceutiska kompositioner innehallande desamma
IT8621066A0 (it) Procedimento per la preparazione di composti eterociclici azotati.
NO852796L (no) Fremgangsmaate for fremstilling av nitroapovincamin-syrederivater.
NO871721L (no) Fremgangsmaate for fremstilling av nye ergolenderivater.
NO884442L (no) Fremgangsmaate for fremstilling av 3,3-disubstituerte indoliner.
DE3676116D1 (de) Herstellung von azetidin-derivaten.
NO890216D0 (no) Fremgangsmaate for revitalisering av forstkulturer.
DE3689997D1 (de) Verfahren zur Herstellung von Maltose-Derivaten.
DK74594A (da) Fremgangsmåde til fremstilling af paroxetin eller et farmaceutisk acceptabelt salt deraf
FR2585354B1 (fr) Procede stereoselectif de preparation de derives de la proline

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: A/S FERROSAN